Bone involvement in patients with lymphoma: the role of FDG-PET/CT
- 22 September 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (1), 60-67
- https://doi.org/10.1007/s00259-006-0238-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of boneAnnals Of Oncology, 2005
- ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphomaAnnals Of Oncology, 2005
- ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's diseaseAnnals Of Oncology, 2005
- Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphomaBlood, 2005
- Primary Lymphoma of Bone: MRI and CT Characteristics During and After Successful TreatmentAmerican Journal of Roentgenology, 2005
- Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in childrenEuropean Radiology, 2004
- Diagnostic utility of bilateral bone marrow examinationCancer, 2002
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- MRI in the Diagnosis of Primary Lymphoma of BoneJournal of Computer Assisted Tomography, 1992
- The value of staging bone marrow trephine biopsy in Hodgkin's DiseaseEuropean Journal of Haematology, 1987